A case report: 19-year-old male diagnosed with C1q nephropathy requiring renal replacement therapy

C1q nephropathy is a rare glomerular disease. Clinical presentation is diverse and ranges from asymptomatic hematuria or proteinuria to symptoms and signs of nephrotic/nephritic syndrome. On light microscopy, it can be classified into two subtypes: minimal change disease (MCD)/focal segmental glomerulosclerosis (FSGS) group and immune complex mediated proliferative glomerulonephritis group. A case of a 19-year-old male patient presenting nausea and decreased appetite will be reported. The labs showed severe nephrotic syndrome and a progressive kidney injury over a few months that were never diagnosed. The immune workup came back negative. The patient mentioned that he was taking protein shakes a few months earlier for bettering his physical fitness. A renal biopsy was done and showed a major reduction in renal mass and C1q nephropathy. He received steroids without any improvement. He was started on hemodialysis afterward then got transplanted 8 months later. In front of this rapid deterioration, FSGS might be the underlying etiology rather than MCD. Further studies are warranted to establish a connection between protein supplements, and progression of kidney disease.

[1]  B. Rovin,et al.  Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases. , 2021, Kidney international.

[2]  Connie M. Rhee,et al.  The Effects of High-Protein Diets on Kidney Health and Longevity. , 2020, Journal of the American Society of Nephrology : JASN.

[3]  Z. Bhat,et al.  C1q Nephropathy: The Unique Underrecognized Pathological Entity , 2015, Analytical cellular pathology.

[4]  Ting Liu,et al.  C1q nephropathy in an old woman with acute renal failure: a case report and literature review , 2014, Renal failure.

[5]  J. Goebel,et al.  Focal Segmental Glomerulosclerosis in Children: Multivariate Analysis Indicates That Donor Type Does Not Alter Recurrence Risk , 2013, Transplantation.

[6]  Akira Shimizu,et al.  Focal segmental glomerulosclerosis after renal transplantation , 2011, Clinical transplantation.

[7]  P. Malleshappa,et al.  C1q nephropathy presenting as acute renal failure. , 2011, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[8]  Y. Fukuda,et al.  Current status and issues of C1q nephropathy , 2009, Clinical and Experimental Nephrology.

[9]  E. Schwedt,et al.  Nefropatía C1q en un paciente de 17 años: Caso clínico , 2008 .

[10]  A. Sinha,et al.  Rituximab in patients with the steroid-resistant nephrotic syndrome. , 2007, The New England journal of medicine.

[11]  J. Jennette,et al.  C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.